RxSight, Inc.
RXST
$6.26
-$0.23-3.54%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.76% | 16.71% | -43.91% | -37.93% | 6.31% |
| Total Depreciation and Amortization | -0.35% | 10.05% | -1.15% | 65.61% | -58.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.47% | -21.15% | 59.95% | 1.19% | 18.69% |
| Change in Net Operating Assets | -66.53% | 272.26% | 83.68% | -76.31% | -288.69% |
| Cash from Operations | 5.98% | 72.87% | 50.45% | -107.32% | -755.38% |
| Capital Expenditure | -95.70% | 62.20% | -167.30% | 32.11% | 23.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -0.64% | -152.03% | -24.46% | 888.92% | 126.57% |
| Cash from Investing | -6.77% | -161.45% | -29.74% | 1,479.92% | 114.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 147.37% | -533.33% | 76.92% | -8.33% | -9.09% |
| Issuance of Common Stock | 706.11% | -93.67% | 197.13% | -76.71% | -22.09% |
| Repurchase of Common Stock | 99.69% | -- | 100.00% | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | 300.57% | -125.67% | 380.95% | -124.70% | 238.95% |
| Foreign Exchange rate Adjustments | -650.00% | -114.29% | 133.33% | 150.00% | -271.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.70% | -186.79% | 9.39% | 46,958.33% | 100.31% |